gabapentin has been researched along with Acute Confusional Senile Dementia in 19 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Following PRISMA guidelines, we systematically reviewed evidence for gabapentin and pregabalin against BPSD symptoms of agitation or aggression in any dementia, using six databases (Pubmed, CINHL, PsychINFO, HealthStar, Embase, and Web of Science)." | 5.01 | Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. ( Abdool, PS; Asmer, S; Bolea-Alamanac, BM; Davies, SJC; Supasitthumrong, T; Woo, VL, 2019) |
| " In the New Drug Application for gabapentin, data from two adequate and well-controlled clinical trials was submitted to the Food and Drug Administration (FDA) in support of the approval of the indication for the treatment of post-herpetic neuralgia." | 4.82 | How modeling and simulation have enhanced decision making in new drug development. ( Corrigan, BW; Donevan, S; El-Kattan, A; Ewy, W; Feltner, DE; Hermann, D; Koup, JR; Kowalski, KG; Lalonde, RL; Li, CS; Lockwood, P; Miller, R; Ouellet, D; Werth, JL, 2005) |
| " Examining antiepileptic prescribing to residents with ADRD who had disruptive behaviors and/or reported pain suggests that two of the most common antiepileptics, valproic acid and gabapentin, are being used in clinically distinct ways." | 4.31 | Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications. ( Candon, M; Gerlach, LB; Maust, DT; Strominger, J, 2023) |
| "Gabapentin has been administered to several geriatric patients with bipolar disorder and patients with dementia." | 2.44 | Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. ( Kim, Y; Tampi, RR; Wilkins, KM, 2008) |
| " Through molecular screening targeting the C terminal region of Aβ, a region involved in the toxic properties of the peptide, we detected an FDA approved compound, gabapentin (GBP), with neuroprotective effects against Aβ toxicity." | 1.56 | Gabapentin Inhibits Multiple Steps in the Amyloid Beta Toxicity Cascade. ( Aguayo, LG; Bascuñán, D; Bobadilla-Azócar, C; Boopathi, S; Burgos, CF; Fernández-Pérez, A; Fernández-Pérez, EJ; Figueroa, M; González, W; González-Sanmiguel, J; Riffo-Lepe, N; Vicente, B, 2020) |
| " Chronic administration of the synthetic gonadotropin (luteinising hormone) releasing hormone analogue, goserelin, reduces testosterone activity." | 1.33 | Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report. ( Raskind, MA; Rosin, RA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Boopathi, S | 2 |
| Poma, AB | 1 |
| Garduño-Juárez, R | 1 |
| Oh, GY | 1 |
| Moga, DC | 1 |
| Abner, EL | 1 |
| Candon, M | 1 |
| Strominger, J | 1 |
| Gerlach, LB | 1 |
| Maust, DT | 1 |
| González-Sanmiguel, J | 1 |
| Burgos, CF | 1 |
| Bascuñán, D | 1 |
| Fernández-Pérez, EJ | 1 |
| Riffo-Lepe, N | 1 |
| Fernández-Pérez, A | 1 |
| Bobadilla-Azócar, C | 1 |
| González, W | 1 |
| Figueroa, M | 1 |
| Vicente, B | 1 |
| Aguayo, LG | 1 |
| Aman, Y | 1 |
| Pitcher, T | 1 |
| Ballard, C | 1 |
| Malcangio, M | 1 |
| Supasitthumrong, T | 1 |
| Bolea-Alamanac, BM | 1 |
| Asmer, S | 1 |
| Woo, VL | 1 |
| Abdool, PS | 1 |
| Davies, SJC | 1 |
| Cooney, C | 1 |
| Murphy, S | 1 |
| Tessema, H | 1 |
| Freyne, A | 1 |
| Biselx, S | 1 |
| Büla, C | 1 |
| Ghika, J | 1 |
| Alkhalil, C | 1 |
| Hahar, N | 1 |
| Alkhalil, B | 1 |
| Zavros, G | 1 |
| Lowenthal, DT | 1 |
| Raudino, F | 1 |
| Mascalzi, MG | 1 |
| Zagami, A | 1 |
| Rosin, RA | 1 |
| Raskind, MA | 1 |
| Miller, R | 2 |
| Ewy, W | 2 |
| Corrigan, BW | 2 |
| Ouellet, D | 1 |
| Hermann, D | 1 |
| Kowalski, KG | 2 |
| Lockwood, P | 1 |
| Koup, JR | 1 |
| Donevan, S | 1 |
| El-Kattan, A | 1 |
| Li, CS | 1 |
| Werth, JL | 1 |
| Feltner, DE | 1 |
| Lalonde, RL | 2 |
| Hutmacher, MM | 1 |
| Nichols, DJ | 1 |
| Milligan, PA | 1 |
| Lockwood, PA | 1 |
| Marshall, SA | 1 |
| Benincosa, LJ | 1 |
| Tensfeldt, TG | 1 |
| Parivar, K | 1 |
| Amantea, M | 1 |
| Glue, P | 1 |
| Koide, H | 1 |
| Kim, Y | 1 |
| Wilkins, KM | 1 |
| Tampi, RR | 1 |
| Regan, WM | 1 |
| Gordon, SM | 1 |
| Sheldon, LJ | 1 |
| Ancill, RJ | 1 |
| Holliday, SG | 1 |
| Roane, DM | 1 |
| Feinberg, TE | 1 |
| Meckler, L | 1 |
| Miner, CR | 1 |
| Scicutella, A | 1 |
| Rosenthal, RN | 1 |
| Dallocchio, C | 1 |
| Buffa, C | 1 |
| Mazzarello, P | 1 |
| Moretti, R | 1 |
| Torre, P | 1 |
| Antonello, RM | 1 |
| Cazzato, G | 1 |
5 reviews available for gabapentin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Anxiety Agents; Gabapentin; Humans; Hydroxyq | 2021 |
Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.
Topics: Aged; Aggression; Alzheimer Disease; Calcium Channel Blockers; Dose-Response Relationship, Drug; Gab | 2019 |
How modeling and simulation have enhanced decision making in new drug development.
Topics: Alzheimer Disease; Amines; Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III a | 2005 |
Model-based drug development.
Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, | 2007 |
Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amines; Behavior; Cyclohexanecarboxylic Acids; Dementia, | 2008 |
1 trial available for gabapentin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients.
Topics: Acetates; Aged; Alzheimer Disease; Amines; Behavior; Cyclohexanecarboxylic Acids; Excitatory Amino A | 2001 |
13 other studies available for gabapentin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Gabapentin utilization among older adults with different cognitive statuses enrolled in the National Alzheimer's Coordinating Center (2006-2019).
Topics: Aged; Alzheimer Disease; Analgesics, Opioid; Antidepressive Agents; Antipsychotic Agents; Benzodiaze | 2023 |
Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications.
Topics: Aged; Alzheimer Disease; Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Gabapentin; Huma | 2023 |
Gabapentin Inhibits Multiple Steps in the Amyloid Beta Toxicity Cascade.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Gabapentin; Hippocampus; Humans; Neurons; Peptide | 2020 |
Impaired chronic pain-like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analgesics; Analgesics, Opioid; Animals; Arthralg | 2019 |
Use of low-dose gabapentin for aggressive behavior in vascular and Mixed Vascular/Alzheimer Dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Amines; Cyclohexanecarboxylic Acids; Dementi | 2013 |
[Restless legs syndrome in the elderly: an unrecognized disorder].
Topics: Aged, 80 and over; Alzheimer Disease; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxyli | 2008 |
Can gabapentin be a safe alternative to hormonal therapy in the treatment of inappropriate sexual behavior in demented patients?
Topics: Acetates; Aged; Alzheimer Disease; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyr | 2003 |
Gabapentin and behavioral disorders in severe Alzheimer disease.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Amines; Cyclohexanecarboxylic Acids; Female; F | 2004 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarbo | 2005 |
Gabapentin for behavioral agitation in Alzheimer's disease.
Topics: Acetates; Aged; Alzheimer Disease; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Admini | 1997 |
Gabapentin in geriatric psychiatry patients.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Amines; Anticonvulsants; Bipolar Disorder; Cyc | 1998 |
Treatment of dementia-associated agitation with gabapentin.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Amines; Anticonvulsants; Cyclohexanecarboxylic | 2000 |
Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Amines; Anticonvulsants; Cholinesterase Inhibi | 2000 |